SCHEMBL18196922

SCHEMBL18196922

CNCc1cn(S(=O)(=O)c2cccc(C(F)(F)F)c2)c(-c2c(F)cc(F)cc2F)c1OC

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 8/20 0.40
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HTR6 P50406 4/20 0.36
▸ LMNA P02545 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20530206 0.99 RORC (0.39) RORCALDH1A1KDM4EGAAMAPT
SCHEMBL18196932 0.94 ALDH1A1 (0.40) RORCALDH1A1KDM4EGAAMAPT
Hydrochloric Acid SCHEMBL20530242 0.94 ALDH1A1 (0.39) RORCALDH1A1KDM4EGAAMAPT
SCHEMBL18196926 0.90 ALDH1A1 (0.37) RORCALDH1A1KDM4EGAAMAPT
SCHEMBL18196882 0.89 HTR6 (0.39) MAPTHTR6KMT2A
SCHEMBL18196929 0.89 RORC (0.37) RORCALDH1A1KDM4EGAAMAPT
Hydrochloric Acid SCHEMBL18190947 0.89 GAA (0.36) RORCALDH1A1KDM4EGAAMAPT
Hydrochloric Acid SCHEMBL20530218 0.89 HTR6 (0.39) GAAMAPTHTR6KMT2A
Hydrochloric Acid SCHEMBL20530240 0.88 RORC (0.37) RORCALDH1A1KDM4EGAAMAPT
SCHEMBL18196924 0.88 HTR6 (0.41) ALDH1A1MAPTL3MBTL1HTR6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same GIPR, GRPR, HTR3E RORC 305/4885ALDH1A1 1906/4885KDM4E 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback